Related Articles for PubMed (Select 18435852)

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

Komajda M, Curtis P, Hanefeld M, Beck-Nielsen H, Pocock SJ, Zambanini A, Jones NP, Gomis R, Home PD; RECORD Study Group.

Cardiovasc Diabetol. 2008 Apr 24;7:10.

PMID: 18435852 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.

Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA.

Diabetes Care. 2006 Nov;29(11):2371-7.

PMID: 17065670 [PubMed - indexed for MEDLINE]

Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.

Bakris GL, Ruilope LM, McMorn SO, Weston WM, Heise MA, Freed MI, Porter LE.

J Hypertens. 2006 Oct;24(10):2047-55.

PMID: 16957566 [PubMed - indexed for MEDLINE]

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

Clin Ther. 2004 May;26(5):744-54.

PMID: 15220018 [PubMed - indexed for MEDLINE]

10:

Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.

Derosa G, Gaddi AV, Piccinni MN, Ciccarelli L, Salvadeo S, Peros E, Ghelfi M, Ferrari I, Cicero AF.

Pharmacotherapy. 2005 May;25(5):637-45.

PMID: 15899724 [PubMed - indexed for MEDLINE]

11:

Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.

Ruilope LM, Usan L, Segura J, Bakris GL.

J Hypertens. 2004 Jan;22(1):217-22.

PMID: 15106814 [PubMed - indexed for MEDLINE]

12:

A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol.

Gupta M, Braga MB, Verma S.

Can J Cardiol. 2008 Oct;24(10):e65-9.

PMID: 18841263 [PubMed - indexed for MEDLINE]

13:

Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?

Wulffelé MG, Kooy A, Lehert P, Bets D, Donker AJ, Stehouwer CD.

Diabet Med. 2005 Jul;22(7):907-13.

PMID: 15975107 [PubMed - indexed for MEDLINE]

14:

Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin.

Derosa G, Fogari E, Cicero AF, D'Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Gravina A, Ferrari I, Fogari R.

Hypertens Res. 2007 May;30(5):387-94.

PMID: 17587750 [PubMed - indexed for MEDLINE]

15:

Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance.

Nilsson PM, Hedblad B, Donaldson J, Berglund G.

Blood Press. 2007;16(2):95-100.

PMID: 17612907 [PubMed - indexed for MEDLINE]

16:

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

J Clin Pharm Ther. 2006 Aug;31(4):375-83.

PMID: 16882108 [PubMed - indexed for MEDLINE]

17:

A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

Clin Ther. 2007 Sep;29(9):1900-14.

PMID: 18035190 [PubMed - indexed for MEDLINE]

18:

Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.

Ahmad AM, Hopkins MT, Weston PJ, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2002 Apr;56(4):431-7.

PMID: 11966735 [PubMed - indexed for MEDLINE]

19:

Pioglitazone reduces blood pressure in non-dipping diabetic patients.

Negro R, Dazzi D, Hassan H, Pezzarossa A.

Minerva Endocrinol. 2004 Mar;29(1):11-7. English, Italian.

PMID: 15258553 [PubMed - indexed for MEDLINE]

20:

Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study.

Goldstein BJ, Weissman PN, Wooddell MJ, Waterhouse BR, Cobitz AR.

Curr Med Res Opin. 2006 Sep;22(9):1715-23.

PMID: 16968575 [PubMed - indexed for MEDLINE]

Recent Activity